PROCEPT BioRobotics Corporation
Price Action
Technical Summary
DOWNTRENDPROCEPT BioRobotics Corporation is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 25), showing significant lag compared to the market leaders. Earnings contraction of 24% provides fundamental context to the price action. Investors should exercise caution due to high volatility (58% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $24.32 | +1.98% | ABOVE |
| 50 SMA | $25.03 | -0.93% | BELOW |
| 100 SMA | $27.96 | -11.32% | BELOW |
| 150 SMA | $29.66 | -16.39% | BELOW |
| 200 SMA | $32.81 | -24.41% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is PRCT in an uptrend right now?
PRCT has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is PRCT overbought or oversold?
PRCT's RSI (14) is 53. The stock is in neutral territory, neither overbought nor oversold.
Is PRCT outperforming the market?
PRCT has a Relative Strength (RS) Rating of 25 out of 99. PRCT is currently lagging the broader market.
Where is PRCT in its 52-week range?
PRCT is trading at $24.80, which is 37% of its 52-week high ($66.85) and 11% above its 52-week low ($19.35).
How volatile is PRCT?
PRCT has a Beta of 1.23 and 52-week volatility of 58%. It's more volatile than the S&P 500 - expect bigger swings.